Intracranial Angioplasty and Stent Placement After Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial: Present State and Future Considerations

Journal of Neuroimaging

Volumn 22, Issue 1, 2012, Pages 1-13

  Qureshi, Adnan I ^a   Al Senani, Fahmi M ^a,b   Husain, Shakir ^c   Janjua, Nazli A ^d   Lanzino, Giuseppe ^e   Lavados, Pablo M ^f   Nguyen, Thanh ^g   Raymond, Jean ^h   Shah, Qaisar A ⁱ   Suarez, Jose I ^j   Suri, M Fareed K ^a   Tolun, Reha ^k  

^a UNIVERSITY OF MINNESOTA   (United States)

^b KING FAHAD MEDICAL CITY   (Saudi Arabia)

^c Saket City Hospital   (India)

^d Department of Neurology   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSIDAD DEL DESARROLLO   (Chile)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

ⁱ ABINGTON MEMORIAL HOSPITAL   (United States)

^j BAYLOR COLLEGE OF MEDICINE   (United States)

^k ISTANBUL BILIM UNIVERSITY   (Turkey)

more..

Author keywords

Death; Intracranial angioplasty; Intracranial atherosclerotic disease; Intracranial stent; Randomized clinical trial; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HEPARIN; NADROPARIN; NIMODIPINE; NITINOL; PROBUCOL; TICLOPIDINE; WARFARIN;

ANGIOPLASTY; ANTICOAGULANT THERAPY; CAROTID ENDARTERECTOMY; CONTINUOUS INFUSION; DEATH; ENDOVASCULAR SURGERY; HUMAN; INTRACRANIAL ANGIOPLASTY; INTRACRANIAL STENOSIS; MEDICAL LITERATURE; POPULATION; POSTOPERATIVE COMPLICATION; RECURRENT STROKE; RESTENOSIS; REVIEW; SELF EXPANDING STENT; STENOSIS; STENT; STROKE; SYSTEMATIC REVIEW; VASOSPASM;

ANGIOPLASTY; BLOOD VESSEL PROSTHESIS; COMORBIDITY; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; PREVALENCE; RECURRENCE; STENTS; STROKE; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84855947571     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2011.00685.x     Document Type: Review

References (79)

1. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305-1316.
2. Derdeyn CP, Chimowitz MI. Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial. Neuroimaging Clin N Am 2007;17:355-363, viii-ix.
3. Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365:993-1003.
4. Molyneux A, Kerr R, Stratton I, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002;360:1267-1274.
5. Qureshi AI, Suri MF, Nasar A, et al. Trends in hospitalization and mortality for subarachnoid hemorrhage and unruptured aneurysms in the United States. Neurosurgery 2005;57:1-8; discussion 1-8.
6. Ikawa F, Ohbayashi N, Imada Y, et al. Analysis of subarachnoid hemorrhage according to the Japanese Standard Stroke Registry Study-incidence, outcome, and comparison with the International Subarachnoid Aneurysm Trial. Neurol Med Chir (Tokyo) 2004;44:275-276.
7. Qureshi AI, Hutson AD, Harbaugh RE, et al. Methods and design considerations for randomized clinical trials evaluating surgical or endovascular treatments for cerebrovascular diseases. Neurosurgery 2004;54:248-264; discussion 264-247.
8. SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004;35:1388-1392.
9. Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007;38:1531-1537.
10. Jiang WJ, Xu XT, Jin M, et al. Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results. AJNR Am J Neuroradiol 2007;28:830-834.
11. Suri MF, Tariq N, Siddiq F, et al. Intracranial angioplasty and/or stent placement in octogenarians is associated with a threefold greater risk of periprocedural stroke or death. J Endovasc Ther 2010;17:314-319.
12. Nahab F, Lynn MJ, Kasner SE, et al. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology 2009;72:2014-2019.
13. Kurre W, Berkefeld J, Brassel F, et al. In-hospital complication rates after stent treatment of 388 symptomatic intracranial stenoses: results from the INTRASTENT multicentric registry. Stroke 2010;41:494-498.
14. Qureshi AI, Tariq N, Hassan AE, et al. Predictors and timing of neurological complications following intracranial angioplasty and/or stent placement. Neurosurgery 2011;68:53-60; discussion 60-51.
15. Zaidat OO, Klucznik R, Alexander MJ, et al. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology 2008;70:1518-1524.
16. Gupta R, Schumacher HC, Mangla S, et al. Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology 2003;61:1729-1735.
17. Levy EI, Siddiqui AH, Crumlish A, et al. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke 2009;40:3552-3556.
18. Turan TN, Maidan L, Cotsonis G, et al. Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke 2009;40:505-509.
19. Georgiadis AL, Cordina SM, Vazquez G, et al. Aspirin treatment failure and the risk of recurrent stroke and death among patients with ischemic stroke. J Stroke Cerebrovasc Dis 2011. Aug 9 [Epub ahead of print].
20. Jiang WJ, Xu XT, Du B, et al. Comparison of elective stenting of severe vs. moderate intracranial atherosclerotic stenosis. Neurology 2007;68:420-426.
21. Groschel K, Schnaudigel S, Pilgram SM, et al. A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 2009;40:e340-e347.
22. Jiang WJ, Du B, Leung TW, et al. Symptomatic intracranial stenosis: cerebrovascular complications from elective stent placement. Radiology 2007;243:188-197.
23. Du B, Wong EH, Jiang WJ. Long-term outcome of tandem stenting for stenoses of the intracranial vertebrobasilar artery and vertebral ostium. AJNR Am J Neuroradiol 2009;30:840-844.
24. Siddiqui FM, Hassan AE, Tariq N, et al. Endovascular management of symptomatic extracranial stenosis associated with secondary intracranial tandem stenosis. a multicenter review. J Neuroimaging 2011.
25. Jiang WJ, Wang YJ, Du B, et al. Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke 2004;35:1375-1380.
26. Qureshi AI, Suri MF, Siddiqui AM, et al. Clinical and angiographic results of dilatation procedures for symptomatic intracranial atherosclerotic disease. J Neuroimaging 2005;15:240-249.
27. Schumacher HC, Meyers PM, Higashida RT, et al. Reporting standards for angioplasty and stent-assisted angioplasty for intracranial atherosclerosis. Stroke 2009;40:e348-e365.
28. Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007;38:881-887.
29. Levy EI, Turk AS, Albuquerque FC, et al. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 2007;61:644-650; discussion 650-641.
30. Qureshi AI, Hussein HM, El-Gengaihy A, et al. Concurrent comparison of outcomes of primary angioplasty and of stent placement in high-risk patients with symptomatic intracranial stenosis. Neurosurgery 2008;62:1053-1060; discussion 1060-1052.
31. Siddiq F, Vazquez G, Memon MZ, et al. Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases: a multicenter study. Stroke 2008;39:2505-2510.
32. Siddiq F, Memon MZ, Vazquez G, et al. Comparison between primary angioplasty and stent placement for symptomatic intracranial atherosclerotic disease: meta-analysis of case series. Neurosurgery 2009;65:1024-1033; discussion 1033-1024.
33. Nguyen TN, Zaidat OO, Gupta R, et al. Balloon angioplasty for intracranial atherosclerotic disease: periprocedural risks and short-term outcomes in a multicenter study. Stroke 2011;42:107-111.
34. Fiorella D, Chow MM, Anderson M, et al. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 2007;61:236-242; discussion 242-233.
35. Yu J, Wang L, Deng JP, et al. Treatment of symptomatic intracranial atherosclerotic stenosis with a normal-sized Gateway(™) balloon and Wingspan(™) stent. J Int Med Res 2010;38:1968-1974.
36. Siller-Matula JM, Lang I, Christ G, et al. Calcium-channel blockers reduce the antiplatelet effect of clopidogrel. J Am Coll Cardiol 2008;52:1557-1563.
37. Popma JJ, Ohman EM, Weitz J, et al. Antithrombotic therapy in patients undergoing percutaneous coronary intervention. Chest 2001;119:321S-336S.
38. Smith SC, Jr., Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/SCAI writing committee to update 2001 guidelines for percutaneous coronary intervention). Circulation 2006;113:e166-e286.
39. Briggs C, Guthrie D, Hyde K, Mackie I, et al. Guidelines for point-of-care testing: haematology. Br J Haematol 2007;142:904-915.
40. Paniccia R, Fedi S, Carbonetto F, et al. Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test. Anesthesiology 2003;99:54-59.
41. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999;282:2003-2011.
42. Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke 2009;40:e573-e583.
43. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995;273:1421-1428.
44. Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006;355:1660-1671.
45. Brott TG, Hobson RW 2nd, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010;363:11-23.
46. Hopkins LN, Roubin GS, Chakhtoura EY, et al. The carotid revascularization endarterectomy versus stenting trial: credentialing of interventionalists and final results of lead-in phase. J Stroke Cerebrovasc Dis 2010;19:153-162.
47. Qureshi AI, Abou-Chebl A, Jovin TG. Qualification requirements for performing neurointerventional procedures: a Report of the Practice Guidelines Committee of the American Society of Neuroimaging and the Society of Vascular and Interventional Neurology. J Neuroimaging 2008;18:433-447.
48. Connors JJ 3rd, Sacks D, Furlan AJ, et al. Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology, American Association of Neurological Surgeons, American Society of Interventional and Therapeutic Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, AANS/CNS Cerebrovascular Section, and Society of Interventional Radiology. Radiology 2005;234:26-34.
49. Higashida RT, Meyers PM, Connors JJ, et al. Intracranial angioplasty & stenting for cerebral atherosclerosis: a position statement of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the American Society of Neuroradiology. J Vasc Interv Radiol 2005;16:1281-1285.
50. Meyers PM, Schumacher HC, Higashida RT, et al. Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2009;119:2235-2249.
51. Qureshi AI, Feldmann E, Gomez CR, et al. Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results. J Neuroimaging 2009;19(Suppl 1):1S-10S.
52. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006;37:577-617.
53. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke 2011;42:227-276.
54. Alberts MJ, Latchaw RE, Selman WR, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005;36:1597-1616.
55. Endovascular stent insertion for intracranial atherosclerotic disease. National Institute for Health and Clinical Excellence. Available at: Accessed December 15, 2011.
56. Qureshi AI, Janardhan V, Memon MZ, et al. Initial experience in establishing an academic neuroendovascular service: program building, procedural types, and outcomes. J Neuroimaging 2009;19:72-79.
57. Leifer D, Bravata DM, Connors JJ 3rd, et al. Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:849-877.
58. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-1711.
59. ® System - H010004. 07/08/2009f.
60. Services CfMM. Proposed decision memorandum for intracranial stenting and angioplasty. 2008.
61. Services DoHaH. Federal register. 2006.
62. Qureshi AI, Feldmann E, Gomez CR, et al. Intracranial atherosclerotic disease: an update. Ann Neurol 2009;66:730-738.
63. Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006;113:555-563.
64. Mazighi M, Tanasescu R, Ducrocq X, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology 2006;66:1187-1191.
65. Qureshi AI. Carotid angioplasty and stent placement after EVA-3S trial. Stroke 2007;38:1993-1996.
66. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493-1501.
67. White CJ, Iyer SS, Hopkins LN, et al. Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results. Catheter Cardiovasc Interv 2006;67:503-512.
68. Hopkins LN, Myla S, Grabe E, et al. Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/E2-1 year results in the CABERNET trial. Catheter Cardiovasc Interv 2008;71:950-960.
69. Gray WA, Hopkins LN, Yadav S, et al. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg 2006;44:258-268.
70. Hill MD, Morrish W, Soulez G, et al. Multicenter evaluation of a self-expanding carotid stent system with distal protection in the treatment of carotid stenosis. AJNR Am J Neuroradiol 2006;27:759-765.
71. Gray WA, Yadav JS, Verta P, et al. The CAPTURE registry: results of carotid stenting with embolic protection in the post approval setting. Catheter Cardiovasc Interv 2007;69:341-348.
72. Gruntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet 1978;1:263.
73. Kent KM, Bentivoglio LG, Block PC, et al. Percutaneous transluminal coronary angioplasty: report from the Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 1982;49:2011-2020.
74. Detre K, Holubkov R, Kelsey S, et al. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry. N Engl J Med 1988;318:265-270.
75. Pepine CJ, Holmes DR Jr. Coronary artery stents. American College of Cardiology. J Am Coll Cardiol 1996;28:782-794.
76. Oesterle SN, Whitbourn R, Fitzgerald PJ, et al. The stent decade: 1987 to 1997. Stanford Stent Summit faculty. Am Heart J 1998;136:578-599.
77. Balcon R, Beyar R, Chierchia S, et al. Recommendations on stent manufacture, implantation and utilization. Study group of the working group on coronary circulation. Eur Heart J 1997;18:1536-1547.
78. Schatz RA, Baim DS, Leon M, et al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation 1991;83:148-161.
79. Palesch YY, Tilley BC, Sackett DL, et al. Applying a phase II futility study design to therapeutic stroke trials. Stroke 2005;36:2410-2414.